4//SEC Filing
JENKINS DAVID A 4
Accession 0001654954-23-003613
CIK 0001716621other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:18 PM ET
Size
14.7 KB
Accession
0001654954-23-003613
Insider Transaction Report
Form 4
JENKINS DAVID A
DirectorExec. Chairman of the Board
Transactions
- Conversion
Series X Convertible Preferred Stock
2023-03-23−277.597→ 2,292.339 totalExercise: $0.00→ Common Stock (2,292,339 underlying) - Conversion
Common Stock
2023-03-23+277,597→ 277,597 total - Conversion
Common Stock
2023-03-23+709,703→ 709,703 total(indirect: See footnote) - Conversion
Common Stock
2023-03-23+2,264→ 2,264 total(indirect: See footnote) - Conversion
Series X Convertible Preferred Stock
2023-03-23−709.703→ 5,860.54 total(indirect: See footnote)Exercise: $0.00→ Common Stock (5,860,540 underlying) - Conversion
Series X Convertible Preferred Stock
2023-03-23−2.264→ 18.691 total(indirect: See footnote)Exercise: $0.00→ Common Stock (18,691 underlying)
Footnotes (5)
- [F1]This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.
- [F2]Shares held by a partnership of which the reporting person is the managing member of the managing partner.
- [F3]Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee.
- [F4]Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American.
- [F5]Series X Convertible Preferred Stock has no expiration date.
Documents
Issuer
Ra Medical Systems, Inc.
CIK 0001716621
Entity typeother
Related Parties
1- filerCIK 0001279803
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 5:18 PM ET
- Size
- 14.7 KB